Adherium Limited (ACN 605 352 510) Collins Place, Level 25, 35 Collins Street, Melbourne VIC 3000 Australia www.adherium.com | www.hailie.com | [email protected] QT-090 V1 12 October 2026 Adherium Strengthens Leadership Team Appointing Brad Wilson as Chief Financial Officer...
Appointment of Chief Financial Officer
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Adherium Ltd. has announced the appointment of Brad Wilson as Chief Financial Officer, strengthening its leadership team. This appointment aims to support Adherium's strategic expansion into value-based respiratory care and enhance capital efficiency. Adherium's CEO emphasized that Wilson's expertise aligns with the company's development towards value-based care models.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from Adherium
- AUD$700,000 Short-Term Loan Facility from Barvest Ventures
- Appendix 4G & Corporate Governance Statement
- Annual Report to shareholders
- Adherium Consolidates Funding into A$4.67M Term Loan
- Preliminary Final Report
Later from Adherium
- Partnership with Florida Lung, Asthma & Sleep Specialists
- Notice of Annual General Meeting/Proxy Form
- Additional $750,000 Loan Facility from Barvest Ventures
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium